Inventor
George C. Morton
Inventor
Collegeville, PA, US
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
A61KPreparations for medical, dental or toiletry purposes11%
C07CAcyclic or carbocyclic compounds9%
C07KPeptides9%
C07BGeneral methods of organic chemistry6%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds5%
Y02ATechnologies for adaptation to climate change5%
C40BCombinatorial chemistry3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
10,941,126Bridged bicycloalkyl-substituted aminothiazoles and their methods of use202110,759,750Beta lactams as modulators of glutamate uptake and methods for use thereof202010,729,670Compositions and methods for treatment of insulin resistance202010,513,516Aminothiazole compounds and methods using same20199,115,147'Tricyclic derivatives and their pharmaceutical use and compositions'20158,765,779'Tricyclic derivatives and their pharmaceutical use and compositions'20148,053,450'Amino-benzazoles as P2Y1 receptor inhibitors with pyridine ring and heterocyclic components'20117,470,712'Amino-benzazoles as P2Y1 receptor inhibitors'20087,144,895'Benzene acetamide compounds useful as serine protease inhibitors'20067,138,526'Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives'20067,122,559'Phenylglycine derivatives useful as serine protease inhibitors'20067,067,525'Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same'20066,979,691'Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same'20056,713,487'Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same'20046,710,208'Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and ,-unsaturated carboxylic acid and aldehyde compounds'20046,492,553'Methods for preparing N-(aliphatic or aromatic)carbonyl)-2-aminoaetamide compounds and for cyclizing such compounds'20026,392,010'Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and -unsaturated carboxylic acid and aldehyde compounds'20026,133,409'Process for the solid phase synthesis of aldehyde, ketone, oxime, amine, hydroxamic acid and .alpha..beta.-unsaturated carboxylic acid and aldehyde compounds'20006,127,515'Functionalized resin for the synthesis of amides and peptides'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000Patents assigned to AVENTIS PHARM PROD INC (2)· patent assignee history
2000–2021Based in Collegeville, PA, US· patent location history
2002–2006Patents assigned to AVENTIS PHARMA INC (3)· patent assignee history
2004–2011Patents assigned to BRISTOL MYERS SQUIBB CO (7)· patent assignee history
2004Based in Princeton, NJ, US· patent location history
2014–2015Patents assigned to CEPHALON INC (2)· patent assignee history
2019–2021Patents assigned to Temple University—Of the Commonwealth System of Higher Education (4)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 7 | 2004–2011 |
| Temple University—Of the Commonwealth System of Higher Education | 4 | 2019–2021 |
| AVENTIS PHARMA INC | 3 | 2002–2006 |
| AVENTIS PHARM PROD INC | 2 | 2000 |
| CEPHALON INC | 2 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Collegeville, Pennsylvania, US | 18 | 2000–2021 |
| Princeton, New Jersey, US | 1 | 2004 |